121
Views
6
CrossRef citations to date
0
Altmetric
Papers

Assessment of antioxidants in foods and biological samples: a short critique

&
Pages 441-448 | Received 09 Jul 2009, Accepted 05 Oct 2009, Published online: 29 Jan 2010

References

  • Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, Berenguer M, Chirlaque MD, Dorronsoro M, Jakszyn P, Larrañaga N, 2007. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: Findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin Nutr 85:1634–1642.
  • Aviram M. 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 33(s):85–97.
  • Benzie IFF, Strain JJ. 1996. The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: The FRAP assay. Anal Biochem 239:70–76.
  • Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. J Am Med Assoc 297:842–857.
  • Cao G, Prior RL. 1998. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 44:1309–1315.
  • Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, 1997. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J Am Med Assoc 176:1957–1963.
  • FAO/WHO. 1998. Vitamin and mineral requirements in human nutrition. Report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September.
  • Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. 2006. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 84:762–763.
  • Ghiselli A, Serafini M, Natella F, Scaccini C. 2000. Total antioxidant capacity as a tool to assess redox status: Critical view and experimental data. Free Radic Biol Med 29:1106–1114.
  • Gniwotta C, Morrow JD, Roberts LJ, Kuhn H. 1997. Prostagladin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 17:3236–3241.
  • Grune T, Berger MM. 2007. Markers of oxidative stress in ICU clinical settings: Present and future. Curr Opin Clin Nutr Metab Care 10:712–717.
  • Halliwell B. 2002. Food-derived antioxidants: How to evaluate their importance in food and in vivo. In: Cadenas E, Packer L, editors, Handbook of antioxidants. New York: Marcel Dekker. pp 1–45.
  • Halvorsen BL, Carlsen MH, Phillips KM, Bohn SK, Holte K, Jacobs Jr DR, Blomhoff R. 2006. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr 84:95–135.
  • Harman D. 1956. Aging: A theory based on free radical and radiation chemistry. J Gerontol 11:298–300.
  • Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342:1007–1011.
  • Hoilvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. 1998. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98:1487–1494.
  • Itabe H, Ueda M. 2007. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb 14:1–11.
  • Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S, 2004. Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts. Am J Clin Nutr 80:1508–1520.
  • Kritchevsky SB. 1999. β-Carotene and the prevention of coronary heart disease. J Nutr 129:5–8.
  • Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J. 2004a. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15:67–72.
  • Lagiou P, Samoli E, Tzonou A, Kalandidi A, Peterson J, Dwyer J, Trichopoulos D. 2004b. Intake of specific flavonoid classes and coronary heart disease. A case–control study in Greece. Eur J Clin Nutr 58:1643–1648.
  • Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D. 2008. Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19:813–818.
  • Lambert JD, Sang S, Yang CS. 2007. Possible controversy over dietary polyphenols: Benefits vs risks. Chem Res Toxicol 20:583–585.
  • Loft S, Poulsen HE. 1996. Cancer risk and oxidative DNA damage in man. J Mol Med 74:297–312.
  • Magalhaes LM, Segundo MA, Reis S, Lima JLFC. 2008. Methodological aspects about in vitro evaluation of antioxidant properties. Anal Chim Acta 613:1–19.
  • Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. 2004. Polyphenols: Food sources and bioavailability. Am J Clin Nutr 79:727–747.
  • Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. 2005. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112:651–657.
  • Meuwese MC, Stroes ESG, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. 2007. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. The EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 50:159–165.
  • Miller III ER, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin P-H, Appel LJ. 2005. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: Results from a randomized controlled feeding study. Atherosclerosis 183:175–182.
  • Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84:407–412.
  • Moore K, Roberts LJ. 1998. Measurement of lipid peroxidation. Free Radic Res 28:659–671.
  • Nalsen C. 2006. Measurement and evaluation of antioxidant status and relation to xidative stress in humans. Digital comprehensive summaries of Uppsala dissertations from the Faculty of Medicine 131, Uppsala University. pp 1–71.
  • Niculescu L, Stancu C, Sima A, Toporan D, Simionescu M. 2001. The total peroxyl radical potential in serum─An assay to define the stage of atherosclerosis. J Cell Mol Med 5:285–294.
  • Pellegrini N, Serafini M, Colombi B, Del Rio D, Salvatore S, Bianchi M, Brighenti F. 2003. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 133:2812–2819.
  • Pellegrini N, Serafini M, Salvatore S, Del Rio D, Bianchi M, Brighrnti F. 2006. Total antioxidant capacity of spices, dried fruits, nuts, pulses, cereals and sweets consumed in Italy assessed by three different in vitro assays. Mol Nutr Food Res 50:1030–1038.
  • Pellegrini N, Salvatore S, Valtuena S, Bedogni G, Porrini M, Pala V, Del Rio D, Sieri S, Miglio C, Krogh V, 2007. Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity. J Nutr 137:93–98.
  • Pellegrini N, Miglio C, Del Rio D, Salvatore S, Serafini M, Brighenti F. 2009. Effect of domestic cooking methods on the total antioxidant capacity of vegetables. Int J Food Sci Nutr 1:1–11.
  • Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, La Vecchia C, Dwyer J, Trichopoulos D. 2003. Flavonoid intake and breast cancer risk: A case–control study in Greece. Br J Cancer 89:1255–1259.
  • Polidori MC, Stahl W, Eichler O, Niestrol I, Sies H. 2001. Profiles of antioxidants in human plasma. Free Radic Biol Med 30:456–462.
  • Porrini M, Riso P. 2008. Factors influencing the bioavailability of antioxidants in foods: A critical appraisal. Nutr Metab Cardiovasc Dis 16:647–650.
  • Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, 2003. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORACFL)) of plasma and other biological and food samples. J Agric Food Chem 51:3273–3279.
  • Prior RL, Gu L, Wu X, Jacob RA, Sotoudeh G, Kader AA, Cook RA. 2007. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr 26:170–181.
  • Rautianinen S, Serafini M, Morgenstern R, Prior RL, Wolk A. 2008. The validity and reproducibility of food-frequency questionnaire-based total antioxidant capacity estimates in Swedish women. Am J Clin Nutr 87:1247–1253.
  • Rietjens IMCM, Boersma MG, de Haan L, Spenkelink B, Awad HM, Cnubben NHP, Zanden JJ, van Woude H, van der Alink GM, Koeman JH. 2002. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol 11:321–333.
  • Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, Gutzki FM, Berger J, Frölich JC, Böger RH. 2004. Urinary 8-iso-prostagladin F2alpha as a risk marker in patients with coronary heart disease: A matched case–control study. Circulation 109:843–848.
  • Serafini M, Bellocco R, Wolk A, Ekstrom AM. 2002. Total antioxidant potential of fruit and vegetables and risk of gastric cancer. Gastroenterology 123:985–991.
  • Strazzullo P, Puig JG. 2007. Uric acid and oxidative stress: Relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis 17:409–414.
  • Stephens JW, Gable DR, Hurel SJ, Miller GJ, Cooper JA, Humphries SE. 2006. Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clin Chem 52:446–452.
  • Tsimikas S. 2008. In vivo markers of oxidative stress and therapeutic interventions. Am J Cardiol 101s:34–42.
  • US Department of Agriculture. 2007. Oxygen radical absorbance capacity (ORAC) of selected foods. Available online at: http://www.ars.usda.gov/. Accessed June 15, 2009.
  • Vita JA, Brennan M-L, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF Jr, Hazen SL. 2004. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110:1134–1139.
  • Wang CC, Chu CY, Chu KO, Choy KW, Khaw KS, Rogers MS, Pang CP. 2004. Trolox-equivalent antioxidant capacity assay versus oxygen radical absorbance capacity assay in plasma. Clin Chem 50:952–954.
  • Wayner DDM, Burton GW, Ingold KU, Locke S. 1985. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS 187:33–37.
  • Wu T, Willett W, Rifai N, Shai I, Mansin JE, Rimm EB. 2006. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? J Am Coll Cardiol 48:973–979.
  • Zhang R, Brennan M-L, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL, 2001. Association between myeloperoxidase levels and risk of coronary artery disease. J Am Med Assoc 286:2136–2142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.